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Abstract  
Background: While a majority of Americans are overweight, some individuals maintain a healthy weight 
in spite of fluctuations in energy intake. This study investigates hormonal and metabolic responses to 
short-term overfeeding and underfeeding in individuals recruited as obese-resistant (OR) or obese-prone 
(OP) based on self-identification, BMI, and personal/family weight history.  
Methods: 58 subjects were studied during eucaloric, overfeeding, and underfeeding phases which included 
a 3-day run-in diet, 1-day intervention diet, and a study day on which a test meal containing 25% of daily 
energy intake for the intervention diet was provided. Following the test meal, blood was sampled every 30 
minutes for hormones and metabolites, and appetite was assessed using visual analog scales.   
Results: Overfeeding resulted in increased meal responses for insulin, leptin and triglycerides and 
decreased responses for ghrelin, glucose and free fatty acids (FFA), and underfeeding resulted in decreased 
insulin, PYY, GLP-1 and triglycerides and increased ghrelin and FFA responses. Ghrelin levels were higher 
and insulin levels were lower in the OR as compared to the OP, although these effects were attenuated by 
overfeeding and underfeeding, respectively. Furthermore, there were greater correlations between appetite 
ratings and appetite-related hormones in the OR.   
Conclusions: Few studies have assessed hormonal effects of underfeeding, which here was found to result 
in decreased insulin, PYY and GLP-1, and increased ghrelin.  The greater correlations between appetite 
ratings and appetite-related hormones in the OR suggest that they are more sensitive to short -term energy 
imbalance and thus may be better able to adjust energy intake accordingly.  
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Introduction 
Although the health risks of obesity and 
related metabolic disorders are well-known, 
the prevalence of obesity continues to 
increase, with a majority of Americans now 
overweight or obese (69%) [1]. Periods of 
energy surplus are likely to occur frequently 
and contribute substantially to the gradual 
weight gain seen in most adults.  
Intra-individual coefficients of variation in 
daily food intake average up to +/- 23% [2] 
and it has been shown that US adults consume 
significantly more energy over the weekend 
than they do during weekdays [3]. Evidence 
that brief periods of positive energy balance 
are clinically relevant comes from a study of 
“holiday weight gain” [4]. In this study many 
individuals maintained their body weight over 
the holiday season, while others (largely the 
obese) tended to have large gains over a short 
period of time. Perhaps more importantly, 
weight gained over this brief period of time 
tended to remain. In order to achieve energy 
balance, individuals must either increase 
physical activity in response to these periods, 
decrease energy intake on other days, or gain 
weight [5]. Clearly some individuals maintain 
a healthy weight in spite of fluctuations in 
energy intake. It is of great interest to 
determine what factors prevent these “obese 
resistant” individuals from gaining weight.  
In order to assess these potential 
differences, we compared individuals who 
were resistant to weight gain (obese-resistant 
- OR) to other non-obese individuals who 
were likely to be at risk for weight gain 
(obese-prone - OP). Previously we found that 
thin, OR individuals quickly sensed changes 
in energy balance (short-term overfeeding) 
with significant decreases in subjective 
measures of hunger and increases in satiety, 
and consumption of less energy in the days 
following a period of overfeeding [6]. In 
addition, we have recently found that OP 
subjects, as defined here, not only have 
decreased physical activity and 
down-regulation of fat oxidation at night 
following overfeeding as compared to OR, but 
OP also show altered eating behaviors and 
neuronal responses to food cues [7-9]. It is 
unclear whether differences in the ability to 
adapt energy intake to current energy status 
are related to differences in nutrient sensing 
by the brain, underlying behavioral 
differences, or other physiological 
differences. 
However, differences in hormones and 
metabolites may also affect response to 
energy imbalance. The relationship between 
gut hormones and appetite control has 
increasingly become an area of interest in 
obesity research [10, 11]. While a number of 
studies have evaluated gut hormone levels in 
response to overfeeding [12-15], and others 
have assessed the response to acute weight 
loss [16-20], few have specifically assessed 
the response to acute underfeeding, and none 
have evaluated individuals with variable 
propensity to weight gain.  
This study was, therefore, designed to 
investigate the hormonal and metabolic 
responses to short-term over- and 
underfeeding in OR and OP individuals. 
Although weight gain does not result from 
only one period of overfeeding, the use of a 
model of short-term energy imbalance allows 
us to assess hormonal and appetitive 
responses which are likely to play a role in 
long-term weight trajectories. We 
hypothesized that the OR would be more 
sensitive to changes in levels of 
appetite-related hormones, with more 
significant associations between hormone 
levels and ratings of appetite. 
Methods 
Ethics Statement: This study was conducted 
according to the principles expressed in the 
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Declaration of Helsinki. The study was 
approved by the Colorado Multiple 
Institutional Review Board. All patients 
provided written informed consent for the 
collection of samples and subsequent analysis. 
Subjects: Subjects included healthy men and 
women, ages 25–35 years, without eating 
disorders or depression, who were empirically 
classified as either obese-resistant (OR) or 
obese-prone (OP) as described previously [7-9, 
21, 22]. Subjects who were OR had a body 
mass index (BMI) of 17–25 kg/m2, 
self-reported no first degree relatives with a 
BMI >30 kg/m
2
, and identified themselves as 
constitutionally thin based on their perception 
of difficulty gaining weight despite expending 
little effort to maintain their current weight. 
These individuals responded to 
advertisements asking “Have you always been 
thin?” and reported no history of ever being 
overweight. Individuals who were OP, in 
contrast, responded to the advertisement “Do 
you struggle with your weight?” They had a 
BMI of 20-30 kg/m
2
, had at least one first 
degree relative with a BMI >30 kg/m
2
, 
reported having to put effort into not gaining 
weight, and reported previous attempts to lose 
weight, but were not actively attempting to 
lose weight. All subjects were weight stable 
for at least 3 months before being studied and 
reported that they did not engage in planned 
physical activity more than 3 hours per week. 
OR and OP subjects were matched for sex, 
age (+/- 2 years), and ethnicity/race.  
Study Design and Measurements: Subjects 
first underwent baseline assessments, 
including height, weight and body 
composition measurement (lean body mass, 
fat mass, and fat-free mass) by dual-energy 
x-ray absorptiometry (DEXA) (DPX 
whole-body scanner, Lunar Radiation Corp., 
Madison, WI). Each subject participated in 3 
study phases separated by at least one month 
in a randomized counterbalanced manner, 
with each phase consisting of a 3 day baseline 
eucaloric run-in diet period, followed by an 
intervention diet on day 4, then a study day on 
day 5. Energy intake during the 3-day run-in 
diet was tailored to each individual’s needs so 
as to maintain energy balance, and intake did 
not differ between study phases for each 
subject. The three study phases consisted of 
one of the following on day 4: Eucaloric (EU) 
diet, Overfeeding (OF) by 40% above 
estimated energy needs, or Underfeeding (UF) 
by 40% below baseline caloric intake. During 
all study periods, the diets were made up of 
the same macronutrient composition (50% 
carbohydrate, 30% fat, and 20% protein). 
Estimates of daily energy needs were made 
using lean body mass (as determined by 
DEXA) in the following equation: Resting 
Metabolic Rate (RMR) = (fat free mass • 
23.9) + 372. The estimates were confirmed 
using RMR as assessed by indirect 
calorimetry, multiplied by an activity factor of 
1.3. This method has been used successfully 
by our group to maintain energy balance in a 
number of prior studies [6, 23-27]. All food 
was prepared and provided by the Clinical 
Translational Research Center (CTRC) 
metabolic kitchen. Subjects presented to the 
CTRC every morning, ate breakfast, and 
picked up the remainder of their daily meals. 
Subjects were asked to maintain their usual 
pattern of physical activity and were regularly 
questioned regarding activity and compliance. 
Subjects were asked to not consume any 
alcoholic or calorie-containing beverages 
during the study period. In women, study days 
were scheduled during the follicular phase of 
their menstrual cycle. In order to assess 
weight maintenance, all subjects were asked 
to weigh in on the first day of each study 
phase and this weight was compared to the 
weight obtained at their screening visit, and if 
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the weights differed by more than 3 pounds, 
the subject would not continue with that study 
phase. None of the subjects were excluded 
based on weight changes during the 1 month 
interval between study phases.  
Study Day: Subjects presented to the 
outpatient clinic of the CTRC in the morning 
after an overnight fast of at least 10 hours. 
They were weighed and completed subjective 
appetite ratings measured by visual analog 
scale (VAS). These included ratings of hunger, 
prospective food consumption, and satiety. 
Hunger was rated on a 100-mm line preceded 
by the question, "How hungry do you feel 
right now?" and anchored by "not at all 
hungry" and "extremely hungry" on the right. 
Satiety was rated by the question, “How full 
do you feel right now?” with the anchors "not 
at all" and "extremely” [6].  An intravenous 
catheter was inserted in a dorsal hand vein for 
blood sampling. Blood was drawn at baseline 
for insulin, leptin, glucagon-like peptide-1 
(GLP-1), peptide YY (PYY), ghrelin, glucose, 
free fatty acids (FFA), and triglycerides (TG). 
Subjects then consumed a liquid breakfast 
meal within 20 minutes. The energy content 
of this meal was equal to 25% of the daily 
energy provided by the intervention diet (EU, 
OF or UF) and had an identical macronutrient 
composition. Blood was again sampled at 30, 
60, 90, 120, 150 and 180 minutes after 
initiation of the breakfast meal for insulin, 
leptin, GLP-1, PYY, ghrelin, glucose, FFA, 
and TG. Repeat appetite ratings by VAS were 
also performed 30, 90, 120, 150, and 180 
minutes after the meal. The area under the 
curve (AUC) for all laboratory measures and 
appetite ratings was calculated using the 
trapezoid method [28].  
Laboratory Analyses: Blood samples were 
collected in EDTA-containing tubes, 
centrifuged, placed in aliquot tubes and stored 
at -70 to -80
o
 C until analysis. All assays were 
run after all 3 studies phases were complete 
for each subject. For GLP-1, 30ul of 
dipeptidyl peptidase IV inhibitor was added to 
the 4ml EDTA tube prior to collection. GLP-1 
assays were performed with Alpco 
Diagnostics ELISA (43-GPTHU-E01).  
Insulin concentrations were measured using 
competitive radioimmunoassay (Millipore). 
Radioimmunoassay was used to analyze 
serum leptin (Millipore), serum PYY 
concentrations (Millipore Cat. #PYYT-66HK) 
and total serum ghrelin concentrations 
(Millipore Cat. #GHRT-89HK). All 
radioimmunoassays were performed with a 
Perkin Elmer Wallac Gamma counter using 
Maciel RIA-AID data reduction software. 
Assays for glucose, TG and FFA were 
performed on the Olympus AU400e 
Chemistry Analyzer (Beckman). Reagents 
were purchased from Beckman Coulter for 
glucose and TG and from WACO for FFA. 
Statistical Analyses: Data were analyzed 
using SigmaPlot version 12 (San Jose, CA). 
All results are reported as means and standard 
errors unless otherwise noted. A two-way 
repeated measures ANOVA was used to 
examine the effects of overfeeding and 
underfeeding on all laboratory measures, with 
p values identified for interactions and main 
effects of obesity (OP and OR) and study 
phase (EU, OF and UF). For OP/OR 
comparisons, both the raw laboratory values 
and laboratory values corrected for fat mass 
were used in the analyses. Data are reported 
for comparisons between the EU phase and 
OF or UF, but not for OF as compared to UF 
because these differences are less clinically 
relevant. For laboratory data with missing 
time points, if 2 time points or less were 
missing, then the mean value for the 
corresponding group and phase was put in for 
the missing time point. If >2 time points were 
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missing, the data set for that laboratory value 
in that phase was thrown out. This occurred 
for 6 subjects, 5 subjects with only one 
laboratory value excluded and 1 subject with 
2 laboratory values excluded from the 
analyses. All other values were used in the 
analysis. GLP-1 results were missing for 10 
subjects (4 OR and 6 OP) due to incorrect 
collection. Correlations were determined 
using the Pearson product moment formula. 
All statistical tests were two-tailed with 
significance set at p<0.05.  
Results 
Subjects and baseline characteristics: A 
total of 58 subjects were studied, equally 
divided between male and female (Table 1). 
OP subjects had greater BMI, fat mass and 
percent body fat than OR, but lean body mass 
and fat free mass were not significantly 
different between groups.  
 
 
Table 1 Baseline characteristics. 
 
 
 
 
 
 
 
 
 
Mean ± standard deviation for Obese-Resistant (OR) and Obese-Prone (OP) 
*
p<0.001 
 
Fasting: We first report on the effects of 
OF and UF on fasting levels of hormones 
and metabolites as summarized in Table 2. 
These results reflect the effects of the 
previous day’s diet on these variables. 
One day of OF resulted in an increase in 
leptin (p=0.002) and a decrease in FFA 
(p=0.007) as compared to the EU phase, 
while insulin, glucose, ghrelin, PYY, 
GLP-1 and TG were unaffected by OF. UF 
was associated with a decrease in insulin 
(p=0.032) and PYY (p=0.035) and an 
increase in FFA (p<0.001) compared to 
EU. Leptin, ghrelin, GLP-1, glucose and 
TG, however, were not affected by UF. 
Meal Response: Next we examine the 
acute effects of OF and UF on hormones 
and metabolites over the 3 hours 
following a test meal (Table 3 and Figure 
1). OF resulted in an increase in leptin 
AUC (p<0.001) and a decrease in ghrelin 
AUC (p<0.001) compared to EU, but did 
not affect AUC for PYY or GLP-1. There 
was an increase in the insulin AUC with 
OF compared to the EU phase (p<0.001), 
accompanied by a decrease in glucose 
AUC (p=0.008). FFA AUC was lower 
(p=0.002) and TG AUC was higher in the 
OF (p<0.001) compared to the EU phase. 
 OR OP 
Total n (male/female) 29 (15/14) 29 (14/15) 
Age (years) 30.7 ± 3.4 30.4 ± 3.9 
BMI (kg/m²) 20.9 ± 1.9 26.1 ± 2.8
* 
Lean Body Mass (kg) 48.5 ± 10.3 53.4 ± 10.4 
Fat Mass (kg) 10.7 ± 3.6 22.7 ± 8.0
 *
 
Percent Body Fat 18.8 ± 4.6 28.7 ± 8.0
 *
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Table 2 Fasting values for hormones and metabolites in eucaloric (EU), overfed (OF) and 
underfed (UF) conditions 
 
 
 
 
 
 
 
 
 
 
 
 
Mean ± standard error for all subjects combined  
Peptide YY (PYY), Glucose-like peptide (GLP-1), Free fatty acids (FFA), Triglycerides (TG) 
*
p<0.001 for comparison to EU 
†
p<0.05 for comparison to EU 
 
 
 
Table 3 Area Under Curve (AUC) following a test meal for hormones and metabolites in 
eucaloric (EU), overfed (OF) and underfed (UF) conditions 
 
Mean area under curve ± standard error for all subjects combined  
Peptide YY (PYY), Glucose-like peptide (GLP-1), Free fatty acids (FFA), Triglycerides (TG) 
*
p<0.001 for comparison to EU 
†
p<0.05 for comparison to EU 
 
 EU OF UF 
Insulin (ng/mL) 12.9 ± 0.5 13.7 ± 0.5 11.2 ± 0.5
† 
Leptin (ng/mL) 7.7 ± 0.3 9.1 ± 0.3
† 
7.2 ± 0.3 
Ghrelin (pg/mL) 901.4 ± 12.1 870.9 ± 12.2 892.5 ± 12.1 
PYY (pg/mL) 103.3 ± 2.6 100.0 ± 2.6 93.7 ± 2.6
†
 
GLP-1 (pmol/L) 7.5 ± 0.8 7.0 ± 0.8 5.4 ± 0.8 
Glucose (mg/dL) 83.8 ± 0.7 85.2 ± 0.7 83.7 ± 0.7 
FFA (uEq/L) 525 ± 30 410 ± 30
† 
671 ± 30
* 
TG (mg/dL) 86.7 ± 2.8 89.1 ± 2.8 83.1 ± 2.7 
 EU OF UF 
Insulin (ng/mL x 180 min) 8028 ± 314 9927 ± 310
*
 5303 ± 310
*
 
Leptin (ng/mL x 180 min) 1239 ± 51 1575 ± 50
* 
1176 ± 9.9
 
Ghrelin (pg/mL x 180 min) 135921 ± 1589 125483 ± 1569
* 
142827 ± 1568
†
 
PYY (pg/mL x 180 min) 22045 ± 460 22467 ± 456
 
19622 ± 454
* 
GLP-1 (pmol/L x 180 min) 1857 ± 146 1924 ± 143 1374 ± 139
† 
Glucose (mg/dL x 180 min) 15968 ± 184 15268 ± 182
†
 15622 ± 182
 
FFA (uEq/L x 180 min) 38436 ± 1453 32103 ± 1434
† 
48374 ± 1433
*
 
TG (mg/dL x 180 min) 16582 ± 511 20252 ± 504
* 
14680 ± 504
† 
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Table 4 Hormones and metabolites by feeding phase (EU, OF and UF) and by group (OR and OP)  
 EU  OF  UF 
AUC OP OR  OP OR  OP OR 
Insulin (ng/mL) 9147 ± 436 6908 ± 452
† 
 10956 ± 448 8899 ± 428
† 
 5695 ± 436 4912 ± 440 
Leptin (ng/mL) 1881 ± 72 598 ± 71
* 
 2362 ± 75 789 ± 67
* 
 1826 ± 72 526 ± 69
* 
Ghrelin (pg/mL) 124586 ± 2207 147256 ± 
2286
† 
 116733 ± 
2268 
134233 ± 
2169 
 130877 ± 
2207 
154776 ± 
2226
† 
PYY (pg/mL) 21307 ± 658 22784 ± 644  21342 ± 678 23593 ± 610  18518 ± 658 20725 ± 627 
GLP-1 (pmol/L) 1713 ± 211 2002 ± 203  1909 ± 217 1939 ± 187  1438 ± 202 1309 ± 192 
Glucose (mg/dL) 16332 ± 256 15603 ± 265  15647 ± 263 14889 ± 251  15747 ± 256 15497 ± 258 
FFA (uEq/L) 39277 ± 2018 37596 ± 2090  31318 ± 2073 32888 ± 1983  50513 ± 2018 46234 ± 2035 
TG (mg/dL) 17250 ± 709 15914 ± 735  20431 ± 729 20073 ± 697  15968 ± 709 13393 ± 715 
 
Mean area under curve (AUC) ± standard error  
Peptide YY (PYY), Glucose-like peptide (GLP-1), Free fatty acids (FFA), Triglycerides (TG) 
*
p<0.001 for comparison to OP 
†
p<0.05 for comparison to OP 
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Figure 1 The effects of overfeeding (OF) and underfeeding (UF) as compared to eucaloric feeding (EU) on hormones are 
shown in response to a test meal: A) Insulin area under the curve (AUC) was increased with OF and decreased with UF; 
B) Peptide YY (PYY) AUC was decreased with UF but not affected by OF; C) Ghrelin AUC was decreased with OF and 
increased with UF; and D) Glucagon-like peptide-1 (GLP-1) was decreased with UF but not affected by OF. 
 
UF resulted in an increase in ghrelin AUC 
compared to EU (p=0.002), while PYY AUC 
(p<0.001) and GLP-1 AUC (p=0.037) were lower 
with UF in comparison to EU.  Leptin AUC was 
not affected by UF. UF resulted in lower insulin 
AUC compared to EU (p<0.001), but did not affect 
glucose AUC. FFA AUC was higher (p<0.001) and 
TG AUC was lower (p=0.009) with UF compared 
to EU.  
Group differences: Group differences are 
summarized in Table 4. For all laboratory data, 
there were no interactions between group and phase. 
Fasting ghrelin was lower in the OP compared to 
OR (801.0 ± 49.6 vs. 975.5 ± 49.1 pg/mL, p=0.015, 
mean for all phases), and was significant for all 
phases individually. Ghrelin AUC (mean for all 
phases) was lower in the OP compared to the OR 
(124065 ± 7232 vs. 145422 ± 7227 pg/mL x 180 
min, p=0.041). Ghrelin was lower in the OP in the 
EU (p=0.039) and UF (p=0.028) phases, but not the 
OF phase. When adjusted for fat mass, the group 
differences in ghrelin levels remained significant, 
both across all phases and for each condition 
individually. Baseline insulin sensitivity as 
calculated by homeostasis model of insulin 
resistance (HOMA-IR) did not differ between 
groups. Although there was no difference in fasting 
insulin concentrations, there was a trend toward 
higher insulin AUC (mean for all 3 conditions) in 
the OP as compared to OR (8599 ± 625 vs. 6906 ± 
625 ng/mL x 180 min, p=0.06). Within phases, 
insulin AUC was higher in the OP in the OF 
(p=0.047) and EU (p=0.05) but not UF conditions. 
When adjusted for fat mass, the group differences 
again remained significant across all phases as well 
as for OF, but not EU or UF. Fasting leptin was also 
higher in the OP compared to OR (12.1 ± 1.1 vs. 
3.9 ± 1.0 ng/mL, p<0.001, mean for all phases), as 
was leptin AUC (2023 ± 181 vs. 638 ± 171 ng/mL 
x 180 min, p<0.001, mean for all phases). These 
differences were significant for all 3 phases 
individually as well. However, the differences 
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disappeared after adjusting for fat mass. There were 
no differences between OP and OR for fasting or 
AUC of PYY, GLP-1, glucose, TG or FFA (mean 
for all phases or for any condition individually).  
The difference between AUC for phases (EU-OF 
and EU-UF) were also examined by group for all 
laboratory data. There was a greater difference 
between OF and EU for leptin in the OP as 
compared to OR, but this difference disappeared 
after adjusting for fat mass. For all other laboratory 
analyses, there were no group differences for 
change in AUC by phase. 
Laboratory measures and appetite ratings: OF 
resulted in lower hunger and higher satiety, and UF 
resulted in higher hunger and lower satiety with no 
group differences seen [9]. For both groups 
combined, there was a correlation between insulin 
AUC and satiety AUC (r=0.189, p=0.015). Within 
the OR group, there was a correlation between 
fasting insulin and pre-meal satiety ratings (r=0.279, 
p=0.01) as well as between insulin AUC and satiety 
AUC (r=0.369, p<0.001), but insulin and satiety 
(fasting or AUC) did not correlate within the OP 
group. There was no correlation between ghrelin 
and hunger (fasting or AUC) for both groups 
combined or within groups. A correlation was seen, 
however, between change in ghrelin and change in 
hunger in the early post-meal phase (from 0-30 
min) in the OR group only (r= 0.219, p=0.045). 
There were no correlations between leptin and 
satiety (fasting or AUC) for both groups combined 
or in either group individually. While there were no 
correlations between leptin and hunger for both 
groups combined or in the OP, a correlation was 
seen between fasting leptin and pre-meal hunger 
(r=-0.239, p=0.0287) as well as between leptin 
AUC and hunger AUC (r=-0.216, p=0.0482) in the 
OR group. There were no correlations between 
PYY and satiety (fasting or AUC) for both groups 
combined or in either group individually. 
Correlation was seen between GLP-1 and satiety 
ratings in both groups combined (r=0.152, 
p=0.001), as well as in both the OP (r=0.150, 
p=0.0320) and the OR (r=0.155, p=0.0164) groups 
individually. 
Discussion 
The present study was performed to examine the 
hormonal and metabolic response to short-term 
energy imbalance in individuals screened to be 
resistant to weight gain and obesity (OR) as 
compared to individuals screened to be prone to 
weight gain and obesity (OP). These results 
indicate that short-term overfeeding results in 
increased insulin, leptin and TG response to a meal, 
while a decreased response was seen in ghrelin, 
glucose and FFA. Underfeeding was shown to 
result in not only decreases in meal response for 
insulin and TG and increases in ghrelin and FFA 
but also in decreased response for PYY and GLP-1. 
While it might be expected that OF and UF would 
affect the same hormones in the opposite direction, 
the results of this study do not support that 
hypothesis. In fact, only ghrelin and insulin are 
affected by both OF and UF, while leptin is affected 
only by OF and PYY and GLP-1 are affected only 
by UF.  Between-group comparisons showed that 
the OR had lower insulin responses (EU and OF 
phases), and higher ghrelin responses (EU and UF 
phases).  Differences between OR and OP do not 
explain differences in propensity to gain weight, 
but greater correlations between appetite ratings 
and appetite-related hormones were found in the 
OR as compared to OP individuals, which may 
suggest that OR individuals are more sensitive to 
physiological hunger cues during brief periods of 
energy imbalance. 
Other studies have shown that short-term 
overfeeding results in insulin resistance [29, 30] 
and increases in leptin levels [31, 32]. However, 
studies of ghrelin levels in response to overfeeding 
have had conflicting results, with trials showing 
increased levels [12], no difference [13, 14], or 
decreased post-prandial ghrelin levels [15]. As 
ghrelin is the only known circulating orexigen and 
has been shown to increase food intake and body 
weight in both rodents and humans [33, 34], 
overfeeding would be expected to result in 
decreased ghrelin to counteract the energy surplus.  
While there are many studies of the effects of 
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weight loss on glycemic parameters and gut 
hormones, acute and short-term underfeeding has 
not been studied extensively. Reports of insulin 
sensitivity following short term underfeeding (1-5 
days) have had conflicting results, showing 
decreased insulin sensitivity [35], no change [36], 
or an increase in insulin sensitivity [37]. Our results 
of decreased fasting insulin as well as insulin 
response to a meal are consistent with an 
improvement in insulin sensitivity following a 
period of only one day of underfeeding, although it 
should be noted that the carbohydrate load 
consumed with the UF test meal was smaller than 
that consumed in the other conditions. One other 
study has specifically examined PYY levels in 
response to one day of underfeeding in which PYY 
was also found to be decreased [38]. This finding 
would be expected since PYY is considered to be a 
satiety hormone, being low in the fasted state and 
rising rapidly following a meal [39]. Similarly, 
GLP-1 levels might be expected to be lower after 
underfeeding, as circulating GLP-1 levels have also 
been found to rise after a meal and fall in the fasted 
state, and have been found to reduce food intake 
[11]. However, our finding of reduced levels of 
GLP-1 in the underfed state is novel, as several 
studies have shown that hypocaloric diets resulting 
in weight loss do not affect GLP-1 levels [18-20]. 
Although no studies have examined ghrelin levels 
in response to short-term underfeeding, studies 
examining ghrelin levels in response to hypocaloric 
diets have shown increased ghrelin levels in 
response to diet-induced weight loss [16, 17]. 
These findings are consistent with our results 
showing increased ghrelin levels after one day of 
underfeeding, and would be expected in response 
to an energy deficit. While the findings of 
decreased insulin, PYY, and GLP-1, and increases 
in ghrelin in response to UF are not unexpected 
based on known physiological effects of these 
hormones, these effects have not been previously 
reported in the literature. 
The lower insulin response in the OR group 
could be explained by the difference in baseline 
BMI, as lean individuals have repeatedly been 
shown to be more insulin sensitive [40, 41]. 
However, the results remained significant after 
adjusting for fat mass. Likewise, the higher ghrelin 
levels seen in the OR might be expected since 
ghrelin levels have been shown to be inversely 
correlated with adiposity [42], but again the results 
remained significant after adjusting for fat mass. 
Thus, the differences in insulin and ghrelin 
responses here do not appear to be related to 
baseline differences in fat mass. Moreover, no other 
studies have investigated the correlation between 
subjective ratings of appetite and appetite-related 
hormones in OR as compared to OP individuals. 
Our findings suggest that the OR individuals are 
more sensitive to these physiological cues of 
hunger and satiety, which could in part explain 
their decreased propensity to gain weight. It is 
possible that their increased sensitivity to changes 
in appetite-related hormones allows them to more 
accurately adjust energy intake following periods 
of over-nutrition, thus maintaining weight stability 
while others are likely to gain weight.  
There are limitations to this study that should be 
addressed. While there are inherent problems with 
classifying individuals as being prone or resistant 
to obesity before its development, we believe that 
the most important factor in this categorization is 
self-identification. Subjects were recruited for this 
study with the use of advertisements directed at 
individuals who perceived that they either had a 
tendency to gain weight or a tendency to remain 
thin. These groups have been previously studied as 
defined here, with the hope of determining 
predictors of weight gain over time [7-9, 21, 22]. 
Ultimately, however, it will be the longitudinal 
weight data which is currently being collected that 
will determine whether or not these categories are 
valid. The fact that the two groups differed with 
respect to BMI and fat mass at baseline likely 
reflects the fact that individuals who report 
struggling with their weight and who perceive a 
tendency to gain weight are more likely to have 
already gained weight during their twenties and 
early thirties. While the difference in baseline fat 
mass could be hypothesized to explain the 
decreased insulin and increased ghrelin responses 
seen in the OR, we did not find that the differences 
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were accounted for by fat mass. Moreover, 
differences in fat mass are unlikely to have played a 
role in correlations between hormones and appetite 
ratings. It should also be emphasized that the test 
meals provided on the study days differed in caloric 
content based on condition (EU, or 40% above or 
below for OF and UF respectively) and that this 
affects interpretation of the results. While the 
fasting values for hormones and metabolites reflect 
the state of energy balance created in the previous 
24 hours, the meal response values reflect both the 
fasting levels and the response to a meal of variable 
caloric content.  
Conclusions 
In summary, our results indicate that overfeeding 
results in increases in insulin and leptin with 
decreases in ghrelin levels, while underfeeding 
results in decreases in insulin, PYY and GLP-1, 
with increases in ghrelin levels. The decrease in 
PYY and GLP-1 and concomitant increase in 
ghrelin after underfeeding lend support to the idea 
that caloric restriction (as employed during dieting) 
causes changes in gut hormones that promote food 
intake and might impede weight loss efforts. 
Moreover, the finding that OR individuals show 
greater correlations between these hormones and 
subjective sensations of appetite suggests that these 
individuals may be more sensitive to energy 
imbalance and thus better able to adjust energy 
intake accordingly. 
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